4.7 Article

C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment

期刊

CARDIOVASCULAR RESEARCH
卷 89, 期 2, 页码 362-373

出版社

OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvq292

关键词

C-kit; Cardiac progenitor; Cardiac MSC; Differentiation

资金

  1. EU [LSHB-CT-2004-502988]
  2. FIRB [RBLA035A4X]

向作者/读者索取更多资源

Aims The heart contains c-kit(+) progenitors that maintain cardiac homeostasis. Cardiac c-kit(+) cells are multipotent and give rise to myocardial, endothelial and smooth muscle cells, both in vitro and in vivo. C-kit(+) cells have been thoroughly investigated for their stem cell activity, susceptibility to stress conditions and ageing, as well as for their ability to repair the infarcted heart. Recently, expression of mesenchymal stem cell (MSC) markers and MSC differentiation potency have been reported in cardiac progenitor cells. Based on this evidence, we hypothesized that c-kit(+) cells may have phenotypic and functional features in common with cardiac MSCs. Methods and results Culture of cells obtained from enzymatic dissociation of heart auricle fragments produced a fast-growing fibroblast-like population expressing mesenchymal markers. C-kit(+) cells co-expressing MSC markers were identified in this population, sorted by flow cytometry and cultured in the presence or the absence of unselected cardiac cells from the same patients. Subsets of c-kit(+) cells also co-expressed MSCs markers in vivo, as detected by immunofluorescence analysis of auricle tissue. Ex vivo expanded c-kit(+) cells produced osteoblasts and adipocytes, although less preferentially than bone marrow-derived MSCs, possessed vascular smooth muscle cell features and were induced to differentiate into endothelium-like and cardiac-like cells. Conclusion In line with previous findings, our results indicate that c-kit(+) cardiac progenitors are primitive stem cells endowed with multilineage differentiation ability. They further suggest a possible relationship between these cells and a heart-specific MSC population with cardiovascular commitment potential.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Dysregulation of Iron Metabolism-Linked Genes at Myocardial Tissue and Cell Levels in Dilated Cardiomyopathy

Ilaria Massaiu, Jeness Campodonico, Massimo Mapelli, Elisabetta Salvioni, Vincenza Valerio, Donato Moschetta, Veronika A. Myasoedova, Maria Domenica Cappellini, Giulio Pompilio, Paolo Poggio, Piergiuseppe Agostoni

Summary: By analyzing the gene expression profiles of iron-linked genes at the tissue and single-cell level in heart failure patients, it was found that the iron metabolism in cardiomyocytes is altered, including imbalanced iron ion internalization, decreased internal conversion, increased hemoglobin synthesis, elevated heme externalization, reduced heme cleavage, and up-regulated hepcidin.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Medicine, General & Internal

The LIMA: A Drug-Eluting Graft and Coronary Flow Shock Absorber

Maurizio Pesce, Giulio Pompilio, Jozef Bartunek

MAYO CLINIC PROCEEDINGS (2023)

Article Biochemistry & Molecular Biology

Omics Analyses of Stromal Cells from ACM Patients Reveal Alterations in Chromatin Organization and Mitochondrial Homeostasis

Melania Lippi, Angela Serena Maione, Mattia Chiesa, Gianluca Lorenzo Perrucci, Lara Iengo, Tommaso Sattin, Chiara Cencioni, Matteo Savoia, Andreas M. Zeiher, Fabrizio Tundo, Claudio Tondo, Giulio Pompilio, Elena Sommariva

Summary: Arrhythmogenic cardiomyopathy (ACM) is a genetic disorder characterized by ventricular arrhythmias, contractile dysfunctions and fibro-adipose replacement of myocardium. This study aimed to enhance the understanding of ACM pathogenesis by comparing the epigenetic and gene expression profiles of ACM-CMSCs with healthy control (HC)-CMSCs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell & Tissue Engineering

Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis

Martina Rabino, Erica Rurali, Chiara Zamboni, Davide Rovina, Sara Mallia, Matteo Cauteruccio, Andrea Baggiano, Carlo Maria Giacari, Milena Bellin, Giulio Pompilio

Summary: Coronavirus disease (COVID-19) is caused by SARS-CoV-2 and can lead to respiratory symptoms. Cardiovascular complications are common, including myocarditis, arrhythmias, heart failure, and coagulation abnormalities. In this study, hiPSCs were generated from four COVID-19 patients, two with severe myocarditis and two without, to study the mechanisms underlying the variability in severe cardiac manifestations.

STEM CELL RESEARCH (2023)

Correction Physiology

Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: the impact of full-length dystrophin deficiency (Vol 13, 1030920, 2022)

Jose Manuel Pioner, Lorenzo Santini, Chiara Palandri, Marianna Langione, Bruno Grandinetti, Silvia Querceto, Daniele Martella, Costanza Mazzantini, Beatrice Scellini, Lucrezia Giammarino, Flavia Lupi, Francesco Mazzarotto, Aoife Gowran, Davide Rovina, Rosaria Santoro, Giulio Pompilio, Chiara Tesi, Camilla Parmeggiani, Michael Regnier, Elisabetta Cerbai, David L. Mack, Corrado Poggesi, Cecilia Ferrantini, Raffaele Coppini

FRONTIERS IN PHYSIOLOGY (2023)

Review Medicine, General & Internal

Cells and Materials for Cardiac Repair and Regeneration

Reem Saud Alhejailan, Gloria Garoffolo, Vineesh Vimala Raveendran, Maurizio Pesce

Summary: After more than 20 years of research in regenerative medicine, the best cell types and materials to effectively translate into clinical practice for cardiac diseases are still uncertain. It is now clear that the heart lacks a consistent reservoir of stem cells for generating new myocytes, and other cells may only contribute with their pro-angiogenic or immunomodulatory potential. New developments in somatic cells' reprogramming, material science, and cell biophysics may be helpful in protecting the heart and enhancing its lost regenerative potential.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Cell Biology

Human Hematopoietic Stem/Progenitor Cells in Type One Diabetes Mellitus Treatment: Is There an Ideal Candidate?

Ermes Carulli, Giulio Pompilio, Maria Cristina Vinci

Summary: Type 1 diabetes mellitus (T1DM) is a common autoimmune disease causing the destruction of pancreatic islet beta-cells, resulting in insulin deficiency and reduced life quality. Cell therapy, particularly autologous nonmyeloablative hematopoietic stem cell transplantation (AHST), has shown promising results for restoring insulin independence, but the success rate varies. A comprehensive review of trials involving stem cells, specifically AHST, for T1DM treatment was conducted. Older patients had a significantly higher probability of achieving insulin independence, while patients with a history of ketoacidosis had a significantly lower probability. Further data is needed to determine the ideal candidate profile.
Review Biochemistry & Molecular Biology

Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench

Giovanni Peretto, Elena Sommariva, Chiara Di Resta, Martina Rabino, Andrea Villatore, Davide Lazzeroni, Simone Sala, Giulio Pompilio, Leslie T. Cooper

Summary: In recent years, research has shown that myocardial inflammation (M-Infl) is involved in the pathophysiology and phenotypes of genetically inherited cardiomyopathies, such as dilated and arrhythmogenic cardiomyopathy. M-Infl, which resembles myocarditis, frequently occurs as a clinical manifestation of these cardiac diseases. The emerging role of M-Infl is leading to the discovery of potential targets for treating inflammation and paving the way for new approaches in cardiomyopathies.

BIOMOLECULES (2023)

Article Cell & Tissue Engineering

Ischemic wound revascularization by the stromal vascular fraction relies on host-donor hybrid vessels

Roman Vuerich, Elena Groppa, Simone Vodret, Nadja Annelies Ruth Ring, Chiara Stocco, Fleur Bossi, Chiara Agostinis, Matteo Cauteruccio, Andrea Colliva, Mohammad Ramadan, Francesca Simoncello, Federica Benvenuti, Anna Agnelli, Franca Dore, Flavia Mazzarol, Massimo Moretti, Alice Paulitti, Silvia Palmisano, Nicolo De Manzini, Mattia Chiesa, Manuel Casaburo, Angela Raucci, Daniela Lorizio, Giulio Pompilio, Roberta Bulla, Giovanni Papa, Serena Zacchigna

Summary: Nonhealing wounds have a negative impact on the quality of life for patients and health systems. Skin substitutes have been used, but have limited efficacy due to inadequate vascularization. The use of the stromal vascular fraction (SVF) from adipose tissue shows promise in overcoming this limitation, but additional research is needed to determine its precise mechanism of action.

NPJ REGENERATIVE MEDICINE (2023)

Article Biology

IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype

Salwa Soussi, Lesia Savchenko, Davide Rovina, Jason S. S. Iacovoni, Andrea Gottinger, Maxime Viallettes, Jose-Manuel Pioner, Andrea Farini, Sara Mallia, Martina Rabino, Giulio Pompilio, Angelo Parini, Olivier Lairez, Aoife Gowran, Nathalie Pizzinat

Summary: A study revealed that DMD patients lack the highest molecular weight isoform of dystrophin in their cardiac fibroblasts, leading to altered cell metabolism and mitochondrial function, exacerbating cardiac fibrosis and deterioration of cardiac function.

BIOLOGY DIRECT (2023)

Review Biochemistry & Molecular Biology

Multi-omics in thoracic aortic aneurysm: the complex road to the simplification

Sara Rega, Floriana Farina, Silvia Bouhuis, Silvia de Donato, Mattia Chiesa, Paolo Poggio, Laura Cavallotti, Giorgia Bonalumi, Ilaria Giambuzzi, Giulio Pompilio, Gianluca L. Perrucci

Summary: Thoracic aortic aneurysm (TAA) is a serious condition without etiological therapy. Recent studies have shown that integrating biological targets and etiological mechanisms through -omics approaches, especially metabolomics, can provide valuable insights for TAA diagnosis and therapy.

CELL AND BIOSCIENCE (2023)

Review Physiology

From bedside to the bench: patient-specific hiPSC-EC models uncover endothelial dysfunction in genetic cardiomyopathies

Martina Rabino, Elena Sommariva, Serena Zacchigna, Giulio Pompilio

Summary: Genetic cardiomyopathies are inherited disorders that damage the structure and function of myocardium. Personalized models are needed to uncover their pathological mechanisms and develop therapeutic strategies. Human induced pluripotent stem cell-derived endothelial cells have been less studied but represent a suitable model to investigate the role of dysfunctional endothelium in genetic cardiomyopathies. This review summarizes the main studies using these cells to investigate endothelial dysfunction in genetic-based cardiomyopathies and discusses new potential therapeutic targets.

FRONTIERS IN PHYSIOLOGY (2023)

Article Hematology

A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the Methodology

Marta Verna, Marta Canesi, Valentino Conter, Lawrence Faulkner, Attilio Maria Rovelli, Daniela Silvestri, Ignazio Majolino, Andrea Biondi, Chra Nawfal Abdullah, Vian Faeq Mohammed

Summary: Thalassemia is a common and life-threatening disorder in children in regions prone to hemoglobinopathy, such as the Middle East. Hematopoietic stem cell transplantation (HSCT) is a highly effective and cost-effective treatment for thalassemia. A study in Iraqi Kurdistan demonstrated the successful establishment of an HSCT unit for both adults and children, achieving comparable results to international standards. The success of the program relied on meeting minimum requirements, international collaboration, and capacity-building efforts.

TRANSPLANTATION AND CELLULAR THERAPY (2023)

Article Cardiac & Cardiovascular Systems

Treatment recommendation based on SYNTAX score 2020 derived from coronary computed tomography angiography and invasive coronary angiography

Shinichiro Masuda, Patrick W. Serruys, Shigetaka Kageyama, Nozomi Kotoku, Kai Ninomiya, Scot Garg, Alan Soo, Marie-Angele Morel, John D. Puskas, Jagat Narula, Ulrich Schneider, Torsten Doenst, Kaoru Tanaka, Johan de Mey, Mark La Meir, Antonio L. Bartorelli, Saima Mushtaq, Giulio Pompilio, Daniele Andreini, Yoshinobu Onuma

Summary: This study compared treatment recommendations based on the SYNTAX score 2020 derived from coronary computed tomography angiography (CCTA) and invasive coronary angiography (ICA). The results showed moderate to substantial agreement between the anatomical SYNTAX scores derived from CCTA and ICA, suggesting that CCTA could be used as an alternative to ICA when making decisions regarding the modality of revascularization.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Comparison of the SYNTAX Score 2020 Based on Coronary Artery Computed Tomography or Invasive Coronary Angiography

Patrick W. Serruys, Shinichiro Masuda, Shigetaka Kageyama, Nozomi Kotoku, Kai Ninomiya, Ulrich Schneider, Ulf Teichgraber, Torsten Doenst, John D. Puskas, Jagat Narula, Kaoru Tanaka, Johan de May, Mark La Meir, Antonio L. Bartorelli, Saima Mushtaq, Giulio Pompilio, Daniele Andreini, Yoshinobu Onuma

JACC-CARDIOVASCULAR INTERVENTIONS (2023)

暂无数据